GSK has teamed up with the University of Oxford on a programme that will try to identify the molecular changes in cells in precancerous stages that could form the basis of vaccines to prevent full ...

It does not necessarily reflect the view of The Herald. Drugmaker GSK (GlaxoSmithKline) has said it is “well positioned” to cope with any financial impact from changes to US tariff rules.

EXCLUSIVE: Research into the disease has saved millions of lives and has wide-ranging benefits for the UK, a report says.

The team at GSK are still in the discovery phase ... a former colleague of Dr Ewer at Oxford, produced promising data from a trial in Burkina Faso, that found blood-stage malaria vaccines to ...

The move comes five months after one of the company’s top executives was killed after being shot as he walked to an investor conference in ...

GlaxoSmithKline wants to sell more than a ... the heart of the UK's 'golden triangle', extending between London, Oxford and Cambridge, which houses the lion's share of the country's life science ...

“This is a high-quality study that stands out mainly for its sample size. The results confirm previous findings that people with a history of cold sores have a higher risk of developing Alzheimer’s ...

Anyone listening to the love-in between Donald Trump and Keir Starmer as they announced their trade deal might conclude this ...

As the FTSE 100's pharmaceutical giants nervously await possible US tariffs, could trade levies end up impacting NHS users?

The trial was funded by GSK. Pavord disclosed relationships with AstraZeneca, Chiesi Farmaceutici, Circassia Pharmaceuticals, Fondazione Internazionale Menarini, Genentech, GSK, Knopp, Merck ...